ArticleBMC pulmonary medicine2026
Vitamin D and vitamin D receptor polymorphisms modify cardiovascular outcomes in asthma: a prospective cohort study based on the UK Biobank.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe association between vitamin D (VD) status and cardiovascular disease (CVD) risk in patients with asthma remains unclear, and the role of vitamin D receptor (VDR) polymorphisms in this context is not well established.
objectivesThis study aimed to investigate the associations of vitamin D status and VDR polymorphisms with incident CVD risk in patients with asthma.
methodsWe included 30,534 asthmatic and 251,249 non-asthmatic participants from the UK Biobank. The relationship between serum 25(OH)D levels and CVD risk in asthma was assessed using multivariable-adjusted restricted cubic spline and Cox proportional hazards models. The analyses for effect modification (by VDR polymorphisms) and mediation (by predefined factors) were conducted using Cox models with interaction terms and a bootstrap-based mediation approach (1,000 resamples), respectively. Additionally, CVD risks were compared across 25(OH)D categories between asthmatic and non-asthmatic participants.
resultsA significant L-shaped association was observed between serum 25(OH)D levels and incident CVD risk in patients with asthma (P for nonlinearity = 0.002), with an inflection point at approximately 50 nmol/L. After multivariable adjustment, asthmatic patients with 25(OH)D levels ≥ 75 nmol/L had a significantly lower CVD risk than those with levels < 25 nmol/L (HR: 0.83; 95% CI: 0.76–0.91; P < 0.001). Among asthmatic patients with severe vitamin D deficiency, the T allele of BsmI (rs1544410) and the G allele of TaqI (rs731236) were associated with a significant attenuation of the protective effect of vitamin D against CVD, whereas the A allele of ApaI (rs7975232) significantly enhanced this protective association. Mediation analysis indicated that body mass index, log-transformed C-reactive protein, and glycated hemoglobin accounted for 35.50%, 20.66%, and 9.88% of the total protective effect of vitamin D, respectively. Furthermore, compared with the non-asthmatic population, asthmatic individuals had a higher CVD risk across all 25(OH)D categories, but the magnitude of this excess risk demonstrated a decreasing trend with increasing vitamin D levels.
conclusionsLower vitamin D status is nonlinearly associated with an elevated CVD risk in asthma patients. VDR polymorphisms modify this protective effect in cases of severe vitamin D deficiency. These findings underscore the importance of maintaining adequate 25(OH)D levels for CVD prevention in asthma.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.